[1]
|
张运, 陈韵岱, 傅向华, 等. 冠状动脉微血管疾病诊断和治疗的中国专家共识[J]. 中国循环杂志, 2017, 32: 421-430. doi: 10.3969/j.issn.1000-3614.2017.05.003
Zheng Y, Chen YD, Fu XH, et al. Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases[J]. Zhongguo Xunhuan Zazhi, 2017, 32: 421-430. doi: 10.3969/j.issn.1000-3614.2017.05.003 |
[2]
|
Sara JD, Widmer RJ, Matsuzawa Y, et al. Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease[J]. JACC Cardiovasc Imaging, 2015, 8: 1445-1453. |
[3]
|
Gehrie ER, Reynolds HR, Chen AY, et al. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: Results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) Quality Improvement Initiative[J]. Am Heart J 2009, 158: 688-694. doi: 10.1016/j.ahj.2009.08.004 |
[4]
|
Zhou W, Lee J, Leung ST, et al. Long-Term Prognosis of Patients With Coronary Microvascular Disease Using Stress Perfusion Cardiac Magnetic Resonance[J]. JACC Cardiovasc Imaging, 2021, 14: 602-611. doi: 10.1016/j.jcmg.2020.09.034 |
[5]
|
Siasos G, Tsigkou V, Zaromytidou M, et al. Role of local coronary blood flow patterns and shear stress on the development of microvascular and epicardial endothelial dysfunction and coronary plaque[J]. Curr Opin Cardiol, 2018, 33: 638-644. doi: 10.1097/HCO.0000000000000571 |
[6]
|
Niccoli G, Scalone G, Lerman A, et al. Coronary microvascular obstruction in acute myocardial infarction[J]. Eur Heart J, 2016, 37: 1024-1033. doi: 10.1093/eurheartj/ehv484 |
[7]
|
Del Buono MG, Montone RA, Camilli M, et al. Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review[J]. J Am Coll Cardiol, 2021, 78: 1352-1371. doi: 10.1016/j.jacc.2021.07.042 |
[8]
|
Masi S, Rizzoni D, Taddei S, et al. Assessment and pathophysiology of microvascular disease: recent progress and clinical implications[J]. Eur Heart J, 2021, 42: 2590-2604. doi: 10.1093/eurheartj/ehaa857 |
[9]
|
Gurzau D, Sitar-Taut A, Caloian B, et al. The Role of IL-6 and ET-1 in the Diagnosis of Coronary MicroVascular Disease in Women[J]. J Pers Med, 2021, 11: 965. doi: 10.3390/jpm11100965 |
[10]
|
Ovchinnikov AG, Arefieva TI, Potekhina AV, et al. The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction[J]. Acta Naturae, 2020, 12: 40-51. doi: 10.32607/actanaturae.11154 |
[11]
|
Ligthart S, Marzi C, Aslibekyan S, et al. DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases[J]. Genome Biol, 2016, 17: 255. doi: 10.1186/s13059-016-1119-5 |
[12]
|
Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation[J]. J Am Coll Cardiol, 2013, 62: 263-271. doi: 10.1016/j.jacc.2013.02.092 |
[13]
|
Furman D, Campisi J, Verdin E, et al. Chronic inflamma-tion in the etiology of disease across the life span[J]. Nat Med, 2019, 25: 1822-1832. doi: 10.1038/s41591-019-0675-0 |
[14]
|
Chae WR, Nübel J, Baumert J, et al. Association of depression and obesity with C-reactive protein in Germany: A large nationally representative study[J]. Brain Behav Immun, 2022, 103: 223-231. doi: 10.1016/j.bbi.2022.04.024 |
[15]
|
Recio-Mayoral A, Rimoldi OE, Camici PG, et al. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease[J]. JACC Cardiovasc Imaging, 2013, 6: 660-667. doi: 10.1016/j.jcmg.2012.12.011 |
[16]
|
Bajaj NS, Osborne MT, Gupta A, et al. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients[J]. J Am Coll Cardiol, 2018, 72: 707-717. doi: 10.1016/j.jacc.2018.05.049 |
[17]
|
Selthofer-Relatić K, Bošnjak I, Kibel A, et al. Obesity Related Coronary Microvascular Dysfunction: From Basic to Clinical Practice[J]. Cardiol Res Pract, 2016, 2016: 8173816. |
[18]
|
Wang GR, Zhu Y, Halushka PV, et al. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase[J]. Proc Natl Acad Sci U S A, 1998, 95: 4888-4893. doi: 10.1073/pnas.95.9.4888 |
[19]
|
Wenzl FA, Ambrosini S, Mohammed SA. Inflammation in Metabolic Cardiomyopathy[J]. Front Cardiovasc Med, 2021, 8: 742178. doi: 10.3389/fcvm.2021.742178 |
[20]
|
Tong DC, Whitbourn R, MacIsaac A, et al. High-Sensitivity C-Reactive Protein Is a Predictor of Coronary Microvascular Dysfunction in Patients with Ischemic Heart Disease[J]. Front Cardiovasc Med, 2017, 4: 81. |
[21]
|
Aryan Z, Ghajar A, Faghihi-Kashani S, et al. Baseline High-Sensitivity C-Reactive Protein Predicts Macrovascular and Microvascular Complications of Type 2 Diabetes: A Population-Based Study[J]. Ann Nutr Metab, 2018, 72: 287-295. doi: 10.1159/000488537 |
[22]
|
Candela J, Wang R, White C. Microvascular Endothelial Dysfunction in Obesity Is Driven by Macrophage-Dependent Hydrogen Sulfide Depletion[J]. Arterioscler Thromb Vasc Biol, 2017, 37: 889-899. doi: 10.1161/ATVBAHA.117.309138 |
[23]
|
Tracy EP, Hughes W, Beare JE, et al. Aging-Induced Impairment of Vascular Function: Mitochondrial Redox Contributions and Physiological/Clinical Implications[J]. Antioxid Redox Signal, 2021, 35: 974-1015. doi: 10.1089/ars.2021.0031 |
[24]
|
Barkaway A, Rolas L, Joulia R, et al. Age-related changes in the local milieu of inflamed tissues cause aberrant neutrophil trafficking and subsequent remote organ damage[J]. Immunity, 2021, 54: 1494-1510. doi: 10.1016/j.immuni.2021.04.025 |
[25]
|
Nikolich-Zugich J. The twilight of immunity: emerging concepts in aging of the immune system[J]. Nat Immunol, 2018, 19: 1146. |
[26]
|
Rowe G, Tracy E, Beare JE, et al. Cell therapy rescues aging-induced beta-1 adrenergic receptor and GRK2 dysfunc-tion in the coronary microcirculation[J]. Geroscience, 2021, 44: 329-348. |
[27]
|
Manini TM, Anton SD, Beavers DP, et al. ENabling Reduction of Low-grade Inflammation in SEniors Pilot Study: Concept, Rationale, and Design[J]. J Am Geriatr Soc, 2017, 65: 1961-1968. doi: 10.1111/jgs.14965 |
[28]
|
Arora R, Van Theemsche KM, Van Remoortel S, et al. Constitutive, Basal, and β-Alanine-Mediated Activation of the Human Mas-Related G Protein-Coupled Receptor D Induces Release of the Inflammatory Cytokine IL-6 and Is Dependent on NF-κB Signaling[J]. Int J Mol Sci, 2021, 22: 13254. doi: 10.3390/ijms222413254 |
[29]
|
Calder PC. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance[J]. Biochim Biophys Acta, 2015, 1851: 469-484. doi: 10.1016/j.bbalip.2014.08.010 |
[30]
|
Teissier T, Boulanger E, Cox LS. Interconnections between Inflammageing and Immunosenescence during Ageing[J]. Cells, 2022, 11: 359. doi: 10.3390/cells11030359 |
[31]
|
Amor C, Feucht J, Leibold J, et al. Senolytic CAR T cells reverse senescence-associated pathologies[J]. Nature, 2020, 583: 127-132. doi: 10.1038/s41586-020-2403-9 |
[32]
|
Baar MP, Brandt RMC, Putavet DA, et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging[J]. Cell, 2017, 169: 132-147. doi: 10.1016/j.cell.2017.02.031 |
[33]
|
Muñoz-Espín D, Rovira M, Galiana I, et al. A versatile drug delivery system targeting senescent cells[J]. EMBO Mol Med, 2018, 10: e9355. |
[34]
|
Konst RE, Guzik TJ, Kaski JC, et al. The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions[J]. Cardiovasc Res, 2020, 116: 817-828. doi: 10.1093/cvr/cvaa009 |
[35]
|
Kuwahata S, Hamasaki S, Ishida S, et al. Effect of uric acid on coronary microvascular endothelial function in women: association with eGFR and ADMA[J]. J Atheroscler Thromb, 2010, 17: 259-269. doi: 10.5551/jat.1594 |
[36]
|
Prasad M, Matteson EL, Herrmann J, et al. Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women[J]. Hypertension, 2017, 69: 236-242. doi: 10.1161/HYPERTENSIONAHA.116.08436 |
[37]
|
Kakuta K, Dohi K, Yamamoto T, et al. Coronary Microvascular Dysfunction Restored After Surgery in Inflammatory Bowel Disease: A Prospective Observational Study[J]. J Am Heart Assoc, 2021, 10: e19125. |
[38]
|
Plazak W, Gryga K, Milewski M, et al. Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus[J]. Lupus, 2011, 20: 936-944. doi: 10.1177/0961203311399607 |
[39]
|
Weber B, Stevens E, Barrett L. Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus[J]. J Am Heart Assoc, 2021, 10: e018555. doi: 10.1161/JAHA.120.018555 |
[40]
|
Shin JI, Lee KH, Joo YH, et al. Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review[J]. J Autoimmun, 2019, 103: 102299. doi: 10.1016/j.jaut.2019.06.010 |
[41]
|
Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta[J]. Mol Cell, 2002, 10: 417-426. doi: 10.1016/S1097-2765(02)00599-3 |
[42]
|
Zanatta E, Colombo C, D'Amico G, et al. Inflammation and Coronary Microvascular Dysfunction in Autoimmune Rheu-matic Diseases[J]. Int J Mol Sci, 2019, 20: 5563. doi: 10.3390/ijms20225563 |
[43]
|
He M, Liang X, He L, et al. Endothelial dysfunction in rheumatoid arthritis: the role of monocyte chemotactic protein-1-induced protein[J]. Arterioscler Thromb Vasc Biol, 2013, 33: 1384-1391. doi: 10.1161/ATVBAHA.113.301490 |
[44]
|
Zhang H, Yang K, Chen F, et al. Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications[J]. Front Immunol, 2022, 13: 975367. doi: 10.3389/fimmu.2022.975367 |
[45]
|
Jin Z, Zheng E, Sareli C, et al. Monocyte Chemotactic Protein-Induced Protein 1 (MCPIP-1): A Key Player of Host Defense and Immune Regulation[J]. Front Immunol, 2021, 12: 727861. doi: 10.3389/fimmu.2021.727861 |
[46]
|
Piaserico S, Osto E, Famoso G, et al. Long-term prognostic value of coronary flow reserve in psoriasis patients[J]. Atherosclerosis, 2019, 289: 57-63. doi: 10.1016/j.atherosclerosis.2019.08.009 |
[47]
|
Weber B, Perez-Chada LM, Divakaran S, et al. Coronary microvascular dysfunction in patients with psoriasis[J]. J Nucl Cardiol, 2020, 29: 37-42. |
[48]
|
Garshick MS, Barrett TJ, Wechter T, et al. Inflammasome Signaling and Impaired Vascular Health in Psoriasis[J]. Arterioscler Thromb Vasc Biol, 2019, 39: 787-798. doi: 10.1161/ATVBAHA.118.312246 |
[49]
|
Piaserico S, Osto E, Famoso G, et al. Treatment with tumor necrosis factor inhibitors restores coronary microvascular function in young patients with severe psoriasis[J]. Atherosclerosis, 2016, 251: 25-30. doi: 10.1016/j.atherosclerosis.2016.05.036 |
[50]
|
Lockshin B, Balagula Y, Merola JF. Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis[J]. J Am Acad Dermatol, 2018, 79: 345-352. doi: 10.1016/j.jaad.2018.02.040 |
[51]
|
Guo J, Wei X, Li Q, et al. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury[J]. J Cell Physiol, 2020, 235: 9884-9894. doi: 10.1002/jcp.29802 |
[52]
|
Rasmi Y, Rouhrazi H, Khayati-Shal E, et al. Association of endothelial dysfunction and cytotoxin-associated gene A-positive Helicobacter pylori in patients with cardiac syndrome X[J]. Biomed J, 2016, 39: 339-345. doi: 10.1016/j.bj.2016.01.010 |
[53]
|
Temesgen GB, Menon M, Gizaw ST, et al. Evaluation of Lipid Profile and Inflammatory Marker in Patients with Gastric Helicobacter pylori Infection, Ethiopia[J]. Int J Gen Med, 2022, 15: 271-278. doi: 10.2147/IJGM.S345649 |
[54]
|
Zhang DH, Yuan C, Wang BB, et al. Helicobacter pylori Infection Maybe a Risk Factor for Cardiac Syndrome X[J]. Front Cardiovasc Med, 2022, 9: 823885. doi: 10.3389/fcvm.2022.823885 |
[55]
|
Tanaka T, Matsushita M, Oka Y, et al. Effect of Chlamydia pneumoniae infection on coronary flow reserve and intimal hyperplasia after stent implantation in patients with angina pectoris[J]. Cardiol, 2001, 38: 311. |
[56]
|
Liuba P, Pesonen E, Paakkari I, et al. Acute Chlamydia pneumoniae infection causes coronary endothelial dysfunction in pigs[J]. Atherosclerosis, 2003, 167: 215-222. doi: 10.1016/S0021-9150(03)00019-4 |
[57]
|
Almeida NC, Queiroz MA, Lima SS, et al. Association of Chlamydia trachomatis, C. pneumoniae, and IL-6 and IL-8 Gene Alterations With Heart Diseases[J]. Front Immunol, 2019, 10: 87. doi: 10.3389/fimmu.2019.00087 |
[58]
|
Wagner J, Bojkova D, Shumliakivska M, et al. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants[J]. Basic Res Cardiol, 2021, 116: 42. doi: 10.1007/s00395-021-00882-8 |
[59]
|
Yin J, Wang S, Liu Y, et al. Coronary microvascular dys function pathophysiology in COVID-19[J]. Microcirculation, 2021, 28: e12718. |
[60]
|
Henry BM, Vikse J, Benoit S, et al. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis[J]. Clin Chim Acta, 2020, 507: 167-173. doi: 10.1016/j.cca.2020.04.027 |
[61]
|
Cenko E, Badimon L, Bugiardini R, et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)[J]. Cardiovasc Res, 2021, 117: 2705-2729. doi: 10.1093/cvr/cvab298 |
[62]
|
Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19[J]. Lancet, 2020, 395: 1417-1418 doi: 10.1016/S0140-6736(20)30937-5 |
[63]
|
Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options[J]. Cardiovasc Res, 2020, 116: 1666-1687. doi: 10.1093/cvr/cvaa106 |
[64]
|
Rethy L, Feinstein MJ, Sinha A, et al. Coronary Microvascular Dysfunction in HIV: A Review[J]. J Am Heart Assoc, 2020, 9: e14018. |
[65]
|
Kristoffersen US, Wiinberg N, Petersen CL, et al. Reduction in coronary and peripheral vasomotor function in patients with HIV after initiation of antiretroviral therapy: a longitudinal study with positron emission tomography and flow-mediated dilation[J]. Nucl Med Commun, 2010, 31: 874-880. doi: 10.1097/MNM.0b013e32833d82e6 |
[66]
|
Knudsen A, Thorsteinsson K, Christensen TE, et al. Cardiac Microvascular Dysfunction in Women Living With HIV Is Associated With Cytomegalovirus Immunoglobulin G[J]. Open Forum Infec Dis, 2018, 5: ofy205. doi: 10.1093/ofid/ofy205 |
[67]
|
Leucker TM, Weiss RG, Schär M, et al. Coronary Endothelial Dysfunction Is Associated With Elevated Serum PCSK9 Levels in People With HIV Independent of Low-Density Lipoprotein Cholesterol[J]. J Am Heart Assoc, 2018, 7: e9996. |
[68]
|
Hileman CO, Funderburg NT. Inflammation, Immune Activation, and Antiretroviral Therapy in HIV[J]. Curr HIV/AIDS Rep, 2017, 14: 93-100. doi: 10.1007/s11904-017-0356-x |
[69]
|
靳刚强. 尼可地尔治疗微血管性心绞痛的疗效及其对血管内皮功能的影响[J]. 当代医学, 2016, 22: 131-132. https://www.cnki.com.cn/Article/CJFDTOTAL-DDYI201623091.htm
Jin GQ. Effect of nicorandil on microvascular angina pectoris and its effect on vascular endothelial function[J]. Dangdai Yixue, 2016, 22: 131-132. https://www.cnki.com.cn/Article/CJFDTOTAL-DDYI201623091.htm |
[70]
|
Luo WH, Guo Y, Huang JW, et al. Do Statins Have a Positive Impact on Patients with Coronary Microvascular Dysfunction on Long-Term Clinical Outcome? A Large Retrospective Cohort Study[J]. Biomed Res Int, 2019, 2019: 4069097. |
[71]
|
Juni RP, Kuster DW, Goebel MM, et al. Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin[J]. JACC Basic Transl Sci, 2019, 4: 575-591. doi: 10.1016/j.jacbts.2019.04.003 |